Executive Advisor - Life Science
Kirt Poss is an Executive Partner with Edgewater Capital Partners focused in the Life Science space. Mr. Poss brings more than 25 years of executive healthcare leadership and business growth through M&A to Edgewater. Most recently, he served as CEO-US of ProtaGene, a leading provider of advanced analytics in biopharmaceutical and gene therapy platform development, which was acquired by private equity in 2021. Previously, he founded and served as President and CEO of BioAnalytix, where he led the company from early commercial growth through M&A with Protagen Protein Services in 2019. Before founding BioAnalytix, Mr. Poss co-founded, ran and grew the biomarker imaging company VisEn Medical as President and CEO from early product development through worldwide commercialization and M&A with PerkinElmer in 2010.
Earlier in his career, Mr. Poss worked in healthcare business strategy consulting with Kendall Strategies in Cambridge, MA, where he focused in the pharmaceutical and medical device sectors. Before that he worked in scientific research at the Center for Molecular Imaging Research at the Massachusetts General Hospital and Harvard Medical School. He is a co-author of several scientific publications and multiple patents in biomarker imaging and pharmaceutical development.